← Leaderboards
Vincent Strout
Elusys Therapeutics, Inc.
$5,191,115
Attributed
$5,191,115
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$5,191,115 · 1
By mechanism
UC1$5,191,115 · 1
Top collaborators
No co-investigators on record.
Most similar at Elusys Therapeutics, Inc.
Same institution · by research overlap
- Steven E Pincus$1,289,693
- Robert Gundel$4,407,655
Others in their field
Top investigators on “Anthrax”
- Laurence Lemiale · Emergent Product Development Gaithersbur$61,222,506
- Matthew Duchars$38,000,000
- Sukjoon Park · Emergent Product Development Gaithersbur$31,173,473
- Daniel F. Hoft · Saint Louis University$26,271,892
- David Heimbrook · Leidos Biomedical Research, Inc.$21,781,988
- Donald S. Burke · Johns Hopkins University$21,607,962
Research focus
AnthraxAnthrax ToxinBioterrorism /Chemical WarfareClinical ResearchClinical Trial Phase ICooperative StudyDosageDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationImmunologic Substance Development /PreparationImmunotherapyLaboratory RatMacaca FascicularisMonoclonal AntibodyNeutralizing AntibodyNonhuman Therapy EvaluationPatient Oriented ResearchPharmacokinetics